SEC Form 4 · accession 0001209191-17-052800
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin J Driscoll
Officer — President and CEO · Director
Period of report
Sep 14, 2017
Accepted (ET)
Sep 14, 2017 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2017 | P | 1,000 | $14.84 | A | 55,400 | D |
Table II — derivative securities
No Table II lines on this filing.